H1-antihistamines for primary mast cell activation syndromes: a systematic review.


BACKGROUND Primary mast cell activation syndromes (MCAS) are a group of disorders presenting with symptoms of mast cell mediator release. OBJECTIVES To assess the effectiveness and safety of orally administered H1 -antihistamines in the treatment of primary MCAS compared with placebo and other pharmacologic treatments. METHODS We systematically searched… (More)
DOI: 10.1111/all.12672


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.


Citations per Year

362 Citations

Semantic Scholar estimates that this publication has 362 citations based on the available data.

See our FAQ for additional information.

Slides referencing similar topics